Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Infectious Disease Diagnosis Market by Type (Urine, Blood, Others), By Application (Hospitals and Trauma Centers, Diagnostic Laboratories, Rehabilitation Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Infectious Disease Diagnosis Market by Type (Urine, Blood, Others), By Application (Hospitals and Trauma Centers, Diagnostic Laboratories, Rehabilitation Centers) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 248685 4200 Medical Care 377 191 Pages 4.6 (31)
                                          

Market Overview:


The global infectious disease diagnosis market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of infectious diseases, growing demand for rapid and accurate diagnosis, and technological advancements in diagnostic instruments. Based on type, the global infectious disease diagnosis market is segmented into urine, blood, and others. The blood segment is expected to account for the largest share of the global market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to the increasing incidence of blood-borne infections worldwide. Based on application, the global infectious disease diagnosis market is divided into hospitals and trauma centers, diagnostic laboratories, rehabilitation centers, and others (including research institutes).


Global Infectious Disease Diagnosis Industry Outlook


Product Definition:


Infectious Disease Diagnosis is the process of identifying an infection in a person. The importance of Infectious Disease Diagnosis is that it allows for the correct treatment to be given to the patient.


Urine:


Urine is a body fluid that flows out of the kidneys through the urethra. It is usually sterile but sometimes contains bacteria or other microorganisms. Urine can be collected from patients by placing a special catheter into the bladder and then draining it into a collection bag. The normal volume of urine produced in an adult human being is about 1 litre and it consists of water, salts, urea, uric acid and ketone bodies (byproducts of fat metabolism).


Blood:


Blood is a bodily fluid that contains blood cells, proteins, and chemicals. It plays an important role in the body by providing oxygen and nutrients to the cells. The main functions of blood are to clotting of wounds, transportation of oxygen and carbon dioxide between different parts of the body, removal waste products from tissues, hormones production (in case if taken orally), infection fighting ability (if injected into a person), etc.


Application Insights:


Based on application, the global infectious disease diagnosis market is segmented into hospitals and trauma centers, diagnostic laboratories, rehabilitation centers and others. Hospitals and trauma centers held the largest share in 2017 due to high usage of diagnostics for COVID-19. In addition, hospital based settings are considered to be more favorable for the spread of infection owing to improper hygiene conditions which enables easy transfer of pathogens. This factor is anticipated to hamper demand over the forecast period.


The other segment includes clinics/rehabilitation facilities that provide outpatient services for patients suffering from chronic diseases or injuries as a result of accidents or violence at home country level (i.e., rural areas) or globally (i.e., urban areas).


Regional Analysis:


North America dominated the global market in 2017. This can be attributed to the presence of key players, high adoption rate of advanced technologies, and favorable reimbursement policies & government initiatives. For instance, in February 2015, CDC collaborated with Quest Diagnostics for testing COVID-19 patients at any hospital for rapid diagnosis. In March 2016; FDA approved real-time RT-PCR tests developed by Illumina and published on GenBank that can be used to detect novel Covid-19 infections within a clinical laboratory setting (Hospitals & Diagnostic Laboratories). These factors are expected to continue driving regional growth over the forecast period as well.


Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to increasing incidence rates of infectious diseases coupled with growing healthcare expenditure levels in emerging countries such as China and India.


Growth Factors:


  • Increasing incidence of infectious diseases: The incidence of infectious diseases is increasing at a rapid pace across the globe. This is primarily owing to the changing lifestyle and environmental conditions. This, in turn, is fueling the demand for diagnostic tests for various infections.
  • Technological advancements in diagnostics: The technological advancements in diagnostics are aiding in early diagnosis and treatment of infections. This is propelling the growth of the Infectious Disease Diagnosis market globally.
  • Growing awareness about infectious diseases: There is a growing awareness among people about various types of infections and their symptoms across the globe. This is boosting demand for diagnostic tests for detection of various infections worldwide.

Scope Of The Report

Report Attributes

Report Details

Report Title

Infectious Disease Diagnosis Market Research Report

By Type

Urine, Blood, Others

By Application

Hospitals and Trauma Centers, Diagnostic Laboratories, Rehabilitation Centers

By Companies

Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, bioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, Bio-Rad Laboratories, Inc.

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

191

Number of Tables & Figures

134

Customization Available

Yes, the report can be customized as per your need.


Global Infectious Disease Diagnosis Market Report Segments:

The global Infectious Disease Diagnosis market is segmented on the basis of:

Types

Urine, Blood, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Hospitals and Trauma Centers, Diagnostic Laboratories, Rehabilitation Centers

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Becton Dickinson & Company
  2. Cepheid, Inc.
  3. Abbott Laboratories
  4. bioMerieux SA
  5. Hologic, Inc.
  6. Danaher Corporation
  7. Thermo Fisher Scientific, Inc.
  8. Roche Diagnostics
  9. Alera Inc.
  10. DiaSorin S.p.A.
  11. Quidel Corporation
  12. Bio-Rad Laboratories, Inc.

Global Infectious Disease Diagnosis Market Overview


Highlights of The Infectious Disease Diagnosis Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Urine
    2. Blood
    3. Others
  1. By Application:

    1. Hospitals and Trauma Centers
    2. Diagnostic Laboratories
    3. Rehabilitation Centers
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Infectious Disease Diagnosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Infectious Disease Diagnosis Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Infectious disease diagnosis is the process of identifying and diagnosing a specific infectious disease. This can involve conducting a medical examination, reviewing medical records, and testing blood or other bodily fluids for signs of infection. Infectious diseases can be difficult to diagnose, and may require multiple tests to confirm a diagnosis.

Some of the major companies in the infectious disease diagnosis market are Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, bioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics, Alera Inc., DiaSorin S.p.A., Quidel Corporation, Bio-Rad Laboratories, Inc..

The infectious disease diagnosis market is expected to grow at a compound annual growth rate of 7.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infectious Disease Diagnosis Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Infectious Disease Diagnosis Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Infectious Disease Diagnosis Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Infectious Disease Diagnosis Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Infectious Disease Diagnosis Market Size & Forecast, 2018-2028       4.5.1 Infectious Disease Diagnosis Market Size and Y-o-Y Growth       4.5.2 Infectious Disease Diagnosis Market Absolute $ Opportunity

Chapter 5 Global Infectious Disease Diagnosis Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Infectious Disease Diagnosis Market Size Forecast by Type
      5.2.1 Urine
      5.2.2 Blood
      5.2.3 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Infectious Disease Diagnosis Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Infectious Disease Diagnosis Market Size Forecast by Applications
      6.2.1 Hospitals and Trauma Centers
      6.2.2 Diagnostic Laboratories
      6.2.3 Rehabilitation Centers
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Infectious Disease Diagnosis Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Infectious Disease Diagnosis Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Infectious Disease Diagnosis Analysis and Forecast
   9.1 Introduction
   9.2 North America Infectious Disease Diagnosis Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Infectious Disease Diagnosis Market Size Forecast by Type
      9.6.1 Urine
      9.6.2 Blood
      9.6.3 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Infectious Disease Diagnosis Market Size Forecast by Applications
      9.10.1 Hospitals and Trauma Centers
      9.10.2 Diagnostic Laboratories
      9.10.3 Rehabilitation Centers
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Infectious Disease Diagnosis Analysis and Forecast
   10.1 Introduction
   10.2 Europe Infectious Disease Diagnosis Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Infectious Disease Diagnosis Market Size Forecast by Type
      10.6.1 Urine
      10.6.2 Blood
      10.6.3 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Infectious Disease Diagnosis Market Size Forecast by Applications
      10.10.1 Hospitals and Trauma Centers
      10.10.2 Diagnostic Laboratories
      10.10.3 Rehabilitation Centers
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Infectious Disease Diagnosis Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Infectious Disease Diagnosis Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Infectious Disease Diagnosis Market Size Forecast by Type
      11.6.1 Urine
      11.6.2 Blood
      11.6.3 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Infectious Disease Diagnosis Market Size Forecast by Applications
      11.10.1 Hospitals and Trauma Centers
      11.10.2 Diagnostic Laboratories
      11.10.3 Rehabilitation Centers
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Infectious Disease Diagnosis Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Infectious Disease Diagnosis Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Infectious Disease Diagnosis Market Size Forecast by Type
      12.6.1 Urine
      12.6.2 Blood
      12.6.3 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Infectious Disease Diagnosis Market Size Forecast by Applications
      12.10.1 Hospitals and Trauma Centers
      12.10.2 Diagnostic Laboratories
      12.10.3 Rehabilitation Centers
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Infectious Disease Diagnosis Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Infectious Disease Diagnosis Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Infectious Disease Diagnosis Market Size Forecast by Type
      13.6.1 Urine
      13.6.2 Blood
      13.6.3 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Infectious Disease Diagnosis Market Size Forecast by Applications
      13.10.1 Hospitals and Trauma Centers
      13.10.2 Diagnostic Laboratories
      13.10.3 Rehabilitation Centers
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Infectious Disease Diagnosis Market: Competitive Dashboard
   14.2 Global Infectious Disease Diagnosis Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Becton Dickinson & Company
      14.3.2 Cepheid, Inc.
      14.3.3 Abbott Laboratories
      14.3.4 bioMerieux SA
      14.3.5 Hologic, Inc.
      14.3.6 Danaher Corporation
      14.3.7 Thermo Fisher Scientific, Inc.
      14.3.8 Roche Diagnostics
      14.3.9 Alera Inc.
      14.3.10 DiaSorin S.p.A.
      14.3.11 Quidel Corporation
      14.3.12 Bio-Rad Laboratories, Inc.

Our Trusted Clients

Contact Us